Connect with us

MARE BALTICUM Gaming & TECH Summit 2024

All posts tagged "SciBase Holding AB"

Artificial Intelligence7 months ago

SciBase initiates pilot with Bare Dermatology to advance skin cancer detection in Texas

SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders announced today that they have entered into a collaboration agreement...
Artificial Intelligence8 months ago

SciBase strengthens US team with experienced Dermatology executive

SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders hereby announces that Dan Walker has been appointed as VP US Commercial Operations....
Artificial Intelligence1 year ago

SciBase receives increased US Medicare fee schedules for the Nevisense melanoma test

SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that two Medicare Administrative Contractors (MACs): First Coast Service...
Artificial Intelligence1 year ago

SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations

SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that they have entered into a collaboration agreement with...
Artificial Intelligence1 year ago

SciBase announces collaboration to detect skin barrier dysfunction in infants

SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it has signed an agreement with Johnson & Johnson...
Artificial Intelligence1 year ago

New article discusses EIS as a potential clinical measure of skin barrier integrity

SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a recently published article in the journal ‘Molecular Psychiatry’,...
Artificial Intelligence1 year ago

New study shows Nevisense significantly improves US clinician’s decision-making beyond dermoscopy

SciBase Holding AB (“SciBase”) (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a new clinical study has been published presenting the improvement that...
Artificial Intelligence2 years ago

US study shows that EIS and Nevisense significantly improves clinicians’ diagnostic accuracy

SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a new study published in the US demonstrated...
Artificial Intelligence2 years ago

SciBase receives largest electrode order from a single clinic valued at 60k€

SciBase Holding AB (“SciBase”) [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it has received its single largest order to...
Artificial Intelligence2 years ago

New Study published showing Nevisense impact on clinician confidence and accuracy

SciBase Holding AB (“SciBase”) (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a new study supporting the use of Nevisense in...

Page 1 of 212